Table 1.
Sociodemographic and clinical characteristics of study participants.
| Characteristics (Average (SD)) | CG (n = 7) | IG (n = 10) | p Value | |
|---|---|---|---|---|
| Age (years) | 58 ± 6.81 | 65 ± 12.66 | 0.24 a | |
| Height (m) | 1.62 ± 0.06 | 1.58 ± 0.13 | 0.51 a | |
| Body Mass (kg) | 84.38 ± 16.80 | 72.28 ± 10.43 | 00.16 a | |
| BMI cm/kg | 32.04 ± 7.09 | 28.91 ± 4.34 | 0.37 a | |
| Footwear number | 38.33 ± 0.81 | 38 ± 2.12 | 0.79 a | |
| Diagnosis time (years) | 14 ± 10.23 | 15 ± 7.54 | 0.72 a | |
| Analogic Visual Scale | 8.00 ± 1.91 | 8.00 ± 1.41 | 0.68 a | |
| Sex (%) | F | 5–71.4 | 6–60.00 | 0.62 b |
| M | 2–28.6 | 4–40.00 | ||
| Diabetic Neuropathy (%) | S | 5–71.4 | 9–90.00 | 0.32 b |
| N | 2–28.6 | 1–10.00 | ||
| Skin sensitivity plant right (%) | P | 4–57.1 | 7–70.00 | 0.58 b |
| A | 3–42.9 | 3–30.00 | ||
| Skin sensitivity plant left (%) | P | 2–28.6 | 8–80.00 | 0.03 b* |
| A | 5–71.4 | 2–20.00 | ||
| Neuropathic symptom score (%) | L | 1–14.28 | 1–10.00 | 0.78 b |
| M | 3–42.8 | 6–60.00 | ||
| G | 3–42.8 | 3–30.00 | ||
| Neuropathic impairment score (%) | L | 4–57.10 | 3–80 | 0.49 b |
| M | 1–14.3 | 2–20 | ||
| G | 0 | 0 | ||
| NC | 2–28.6 | 5–50 | ||
at test, b chi-square test; Legend: BMI: body mass index; CG: control group; IG: intervention group; F: female; M: male; S: yes; N: no; P: preserved; A: altered; L: light; M: moderate; G: severe; NC: did not classify. * p value < 0.05.